title: Nocardiosis in Heart Transplant Recipients.
abstract: Nocardia has emerged as an important opportunistic pathogen, especially in organ transplant recipients. Heart transplant (HT) recipients initially had an especially high rate of Nocardia infection, but this could be reduced by the routine use of cyclosporine. Our objective was to clarify the prevalence and presentation of Nocardiosis in HT recipients in a retrospective cross-sectional analysis.
authors.affiliation: Nazih Zudhi Transplant Institute/Advanced Cardiac Care, INTEGRIS Baptist Medical Center, Oklahoma City, Oklahoma.
authors.forename: Michael M
authors.initials: MM
authors.lastname: Koerner
authors.affiliation: Nazih Zudhi Transplant Institute/Advanced Cardiac Care, INTEGRIS Baptist Medical Center, Oklahoma City, Oklahoma.
authors.forename: Aly
authors.initials: A
authors.lastname: El-Banayosy
authors.affiliation: Heart and Diabetes Center, North Rhine-Westphalia, Division of Heart Transplantation, Department of Thoracic and Cardiovascular Surgery, University Hospital of the Ruhr-University Bochum, Bad Oeynhausen, Germanuy.
authors.forename: Uwe
authors.initials: U
authors.lastname: Schulz
authors.affiliation: Nazih Zudhi Transplant Institute/Advanced Cardiac Care, INTEGRIS Baptist Medical Center, Oklahoma City, Oklahoma.
authors.forename: Mohamad
authors.initials: M
authors.lastname: Zeriouh
authors.affiliation: Departmant of Heart and Vascular Surgery, Division for Surgical Therapy of End-Stage Heart Failure and Artificial Heart Support, Evangelisches und Johanniter Klinikum Niederrhein, Duisburg, Germany.
authors.forename: Reiner
authors.initials: R
authors.lastname: Koerfer
authors.affiliation: Departmant of Heart and Vascular Surgery, Division for Surgical Therapy of End-Stage Heart Failure and Artificial Heart Support, Evangelisches und Johanniter Klinikum Niederrhein, Duisburg, Germany.
authors.forename: Gero
authors.initials: G
authors.lastname: Tenderich
authors.affiliation: Heart and Vascular Institute, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
authors.forename: Ali
authors.initials: A
authors.lastname: Ghodsizad
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009617:Nocardia Infections / Q000175:diagnosis* / Q000188:drug therapy; D009894:Opportunistic Infections / Q000175:diagnosis* / Q000188:drug therapy; D011183:Postoperative Complications / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D012189:Retrospective Studies
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine